Searchable abstracts of presentations at key conferences in endocrinology

ea0028s6.3 | Inhibiting steroid enzymes to treat common diseases | SFEBES2012

Dual aromatase and steroid sulphatase inhibition in breast cancer

Foster Paul , Potter Barry , Purohit Atul

The production of oestradiol (E2) is paramount for the growth of oestrogen receptor α positive breast cancer. Various strategies have been used, including the use of enzyme inhibitors against either aromatase (AROM) or steroid sulphatase (STS), in an attempt to ablate E2 levels. Both these enzymes play a critical role in the formation of oestrogenic steroids (see figure 1) and their inhibitors are now showing success in the clinic. The studies presented here demonstrate t...

ea0077p182 | Metabolism, Obesity and Diabetes | SFEBES2021

Rat primary hypothalamic, but not cortical, astrocytes increase use of glutamate to fuel metabolism after recurrent low glucose

Potter Paul Weightman , Randall Andy , Ellacott Kate , Beall Craig

Aims: A critical function of astrocytes is to recycle glutamate to neurons as glutamine to sustain glutamatergic neurotransmission. In the hypothalamus, this is required for effective counterregulatory hormone release in response to hypoglycaemia. However, after recurrent hypoglycaemia in vivo, this is attenuated. The aim of this study was to characterise how rat primary hypothalamic and cortical astrocytes adapt to recurrent low glucose (RLG) with repeated exposure t...

ea0038p2 | Bone | SFEBES2015

Exploring the N-ethyl-N-nitrosourea mutagenesis DNA archive for mutations in nuclear factor I/X to derive mouse models for Marshall-Smith syndrome

Kooblall Kreepa , Stevenson Mark , Piret Sian , Potter Paul , Cox Roger , Brown Steve , Hennekam Raoul , Thakker Rajesh

Marshall-Smith syndrome (MSS) is a congenital disorder affecting skeletal and neural development due to mutations in the nuclear factor I/X (NFIX) gene. Of these mutations, 61% are small insertions/deletions, 12% are splice site mutations and 27% are large exonic deletions clustered in exons 6–10 of the NFIX gene. In order to derive a MSS mouse model, the N-ethyl-N-nitrosourea (ENU) mutagenesis DNA archive was screened ...

ea0065oc3.1 | Bone and Calcium | SFEBES2019

A mouse model generated by CRISPR-Cas9 with a frameshift mutation in the nuclear factor 1/X (NFIX) gene has phenotypic features reported in Marshall-Smith Syndrome (MSS) patients

Kooblall Kreepa , Stevenson Mark , Stewart Michelle , Szoke-Kovacs Zsombor , Hough Tertius , Leng Houfu , Horwood Nicole , Vincent Tonia , Hennekam Raoul , Potter Paul , Cox Roger , Brown Stephen , Wells Sara , Teboul Lydia , Thakker Rajesh

Marshall-Smith syndrome (MSS) is a congenital disorder characterised by developmental delay, short stature, respiratory difficulties, distinctive facial features, skeletal abnormalities (such as kyphoscoliosis, dysostosis and osteopenia) and delayed neural development, and is due to heterozygous mutations that are clustered in exons 6–10 of the transcription factor nuclear factor I/X (NFIX) gene. These frameshift and splice-site NFIX variants result in t...